"Incretins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Peptides which stimulate INSULIN release from the PANCREATIC BETA CELLS following oral nutrient ingestion, or postprandially.
| Descriptor ID |
D054795
|
| MeSH Number(s) |
D27.505.696.399.472.580
|
| Concept/Terms |
Incretins- Incretins
- Glucose-Dependent Insulin-Releasing Hormone
- Glucose Dependent Insulin Releasing Hormone
- Hormone, Glucose-Dependent Insulin-Releasing
- Insulin-Releasing Hormone, Glucose-Dependent
- Incretin
Incretin Effect- Incretin Effect
- Effect, Incretin
- Incretin Effects
- Effects, Incretin
|
Below are MeSH descriptors whose meaning is more general than "Incretins".
Below are MeSH descriptors whose meaning is more specific than "Incretins".
This graph shows the total number of publications written about "Incretins" by people in this website by year, and whether "Incretins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2008 | 1 | 0 | 1 |
| 2015 | 0 | 1 | 1 |
| 2016 | 2 | 0 | 2 |
| 2017 | 8 | 4 | 12 |
| 2018 | 10 | 2 | 12 |
| 2019 | 2 | 2 | 4 |
| 2020 | 2 | 1 | 3 |
| 2021 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Incretins" by people in Profiles.
-
The role of GLP-1 receptor agonists during COVID-19 pandemia: a hypothetical molecular mechanism. Expert Opin Drug Saf. 2021 Nov; 20(11):1309-1315.
-
Pharmacotherapeutic considerations for the management of diabetes mellitus among hospitalized COVID-19 patients. Expert Opin Pharmacother. 2021 Feb; 22(2):229-240.
-
Treating type 2 diabetes in COVID-19 patients: the potential benefits of injective therapies. Cardiovasc Diabetol. 2020 07 22; 19(1):115.
-
Incretin-Based Therapies Role in COVID-19 Era: Evolving Insights. J Cardiovasc Pharmacol Ther. 2020 11; 25(6):494-496.
-
Potential role of incretins in diabetes and COVID-19 infection: a hypothesis worth exploring. Intern Emerg Med. 2020 Aug; 15(5):779-782.
-
Therapeutic Effects of Endogenous Incretin Hormones and Exogenous Incretin-Based Medications in Sepsis. J Clin Endocrinol Metab. 2019 11 01; 104(11):5274-5284.
-
SGLT-2 Inhibitors and GLP-1 Agonists: First-Line Therapy for Diabetes With Established Cardiovascular Disease. J Cardiovasc Pharmacol Ther. 2019 09; 24(5):422-427.
-
Association between increased carotid intima-media thickness and higher serum C-terminal telopeptide of type 1 collagen levels in post-menopausal women with type 2 diabetes. Diabetes Metab. 2020 10; 46(5):409-411.
-
Anti-diabetic treatment leads to changes in gut microbiome. Front Biosci (Landmark Ed). 2019 03 01; 24(4):688-699.
-
Circulating Levels of Soluble Dipeptidyl Peptidase-4 Are Dissociated from Inflammation and Induced by Enzymatic DPP4 Inhibition. Cell Metab. 2019 02 05; 29(2):320-334.e5.